1. Home
  2. SQNS vs ONCY Comparison

SQNS vs ONCY Comparison

Compare SQNS & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sequans Communications S.A.

SQNS

Sequans Communications S.A.

HOLD

Current Price

$3.06

Market Cap

85.3M

Sector

Technology

ML Signal

HOLD

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$0.97

Market Cap

94.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SQNS
ONCY
Founded
2003
1998
Country
Employees
N/A
N/A
Industry
Semiconductors
Pharmaceuticals and Biotechnology
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
85.3M
94.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SQNS
ONCY
Price
$3.06
$0.97
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
6
Target Price
$20.33
$6.00
AVG Volume (30 Days)
260.1K
2.1M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$70.61
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.97
$0.33
52 Week High
$58.30
$1.51

Technical Indicators

Market Signals
Indicator
SQNS
ONCY
Relative Strength Index (RSI) 30.36 50.38
Support Level $3.01 $0.79
Resistance Level $3.81 $1.10
Average True Range (ATR) 0.39 0.11
MACD -0.10 0.00
Stochastic Oscillator 4.39 48.58

Price Performance

Historical Comparison
SQNS
ONCY

About SQNS Sequans Communications S.A.

Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its offer 5G/4G chips and modules fully optimized for non-smartphone devices. The company covers applications such as smart mobility and logistics, smart utility meters, smart cities, smart industries, e-health and wellness, and smart homes to name few. The Company has one operating segment, which is the design and marketing of semiconductor components for cellular wireless systems. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.

Share on Social Networks: